References
Noiret B, Clement G, Lenne X, et al. Centralization and oncologic training reduce postoperative morbidity and failure-to-rescue rates after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: study on a 10-year national french practice. Ann Surgery. 2020;272(5):847–54. https://doi.org/10.1097/SLA.0000000000004326.
van der Ven RGFM, van den Heuvel TBM, Rovers KPB, et al. Towards equal access to cytoreductive surgery with hyperthermic intraperitoneal chemotherapy and survival in patients with isolated colorectal peritoneal metastases: a nationwide population-based study. Ann Surg Oncol. 2024;31:3758. https://doi.org/10.1245/s10434-024-15131-0.
Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis. Europ J Surg Oncol. 2019;45(2):e17. https://doi.org/10.1016/j.ejso.2018.10.086.
van de Vlasakker VCJ, Lurvink RJ, Cashin PH, et al. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: a web-based survey and 2021 statement by peritoneal surface oncology group international (PSOGI). Eur J Surg Oncol. 2021;47(11):2888–92. https://doi.org/10.1016/j.ejso.2021.05.023.
Noiret B, Lenne X, Bruandet A, Piessen G, Eveno C. Should cytoreductive surgery alone for peritoneal metastases of colorectal origin be centralized? A national study of 4159 procedures. Ann Surg Oncol. 2024. https://doi.org/10.1245/s10434-024-15180-5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Guillaume Piessen has undertaken consulting work for BMS, Nestlé, Astellas Pharma, MSD, and Daiichi; is a member of the Advisory Board for BMS; and has received travel and accommodation expenses from Medtronic and MSD. Barbara Noiret and Clarisse Eveno have no disclosures to declare that may be relevant to the contents of this manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article refers to: Noiret B, Lenne X, Bruandet A, Piessen G, Eveno C. Should Cytoreductive Surgery Alone for Peritoneal Metastases of Colorectal Origin be Centralized? A National Study of 4159 Procedures. Annals Surgical Oncology. Epub 28 Mar 2024. https://doi.org/10.1245/s10434-024-15180-5.
Rights and permissions
About this article
Cite this article
Noiret, B., Piessen, G. & Eveno, C. ASO Author Reflections: Centralization of Cytoreductive Surgery Alone in Colorectal Peritoneal Metastases Patients: Optimizing Treatment Pathways. Ann Surg Oncol (2024). https://doi.org/10.1245/s10434-024-15463-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1245/s10434-024-15463-x